Hepatoblastoma in children

被引:5
|
作者
Liu, Chin-Su [1 ]
Wei, Chou-Fu [2 ]
机构
[1] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Sch Med, Dept Surg,Div Pediat Surg,Div Transplant Surg, Taipei, Taiwan
[2] Taipei Med Univ Hosp, Dept Surg, Taipei, Taiwan
关键词
children; hepatoblastoma; liver; pretreatment extension (PRETEXT); transplantation;
D O I
10.1016/j.fjs.2013.04.004
中图分类号
R61 [外科手术学];
学科分类号
摘要
Hepatoblastoma (HB) is the most common malignant tumor of the liver in children in countries where hepatitis B is not endemic, and this has also been the case in Taiwan since nationwide hepatitis B vaccinations were implemented in 1984. The outcome of HB has become much better in the past two decades because of improved imaging modalities, adjuvant and neoadjuvant chemotherapy, and technical improvements in liver resection and liver transplantation. In this mini-review, the current strategy of HB treatment as reported in the literature will be described. Copyright (C) 2013, Taiwan Surgical Association. Published by Elsevier Taiwan LLC. All rights reserved.
引用
收藏
页码:105 / 108
页数:4
相关论文
共 50 条
  • [31] COMBINED AGGRESSIVE THERAPY OF METASTATIC HEPATOBLASTOMA IN CHILDREN
    SWEENEY, N
    LAMPKIN, B
    KOUFOS, A
    KAUFMAN, R
    NOSEWORTHY, J
    CLINICAL RESEARCH, 1986, 34 (04): : A987 - A987
  • [32] Serum type III procollagen in children with hepatoblastoma
    Pitkänen, S
    Perkkiö, M
    Heikinheimo, M
    MEDICAL AND PEDIATRIC ONCOLOGY, 2000, 34 (05): : 366 - 367
  • [33] Prognostic stratification for children with hepatoblastoma: The SIOPEL experience
    Maibach, Rudolf
    Roebuck, Derek
    Brugieres, Laurence
    Capra, Michael
    Brock, Penelope
    Dall'Igna, Patrizia
    Otte, Jean-Bernard
    De Camargo, Beatriz
    Zsiros, Jozsef
    Zimmermann, Arthur
    Aronson, Daniel
    Childs, Margaret
    Scopinaro, Marcelo
    Morland, Bruce
    Plaschkes, Jack
    Czauderna, Piotr
    Perilongo, Giorgio
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (10) : 1543 - 1549
  • [34] Novel therapeutic approaches in the treatment of children with hepatoblastoma
    Katzenstein, HM
    Rigsby, C
    Shaw, PH
    Mitchell, TL
    Haut, PR
    Kletzel, M
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2002, 24 (09) : 751 - 755
  • [35] EFFECTIVENESS OF LIVER TRANSPLANTATION IN CHILDREN WITH UNRESECTABLE HEPATOBLASTOMA
    Broniszczak, Dorota
    Ismail, Hor
    Kalicinski, Piotr
    Tesseyre, Joanna
    Dembowska-Baginska, Bozena
    Perek, Danuta
    Kluge, Przemyslaw
    Kosciesza, Andrzej
    PEDIATRIC TRANSPLANTATION, 2011, 15 : 97 - 97
  • [36] SHOULD CHILDREN WITH HEPATOBLASTOMA BE SCREENED FOR GENETIC ABNORMALITIES?
    Ronghe, Milind
    McIntosh, Diana
    Sastry, Jairam
    Murphy, Dermot
    Davidson, Rosemarie
    Murday, Victoria
    PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 819 - 819
  • [37] CHEMOTHERAPY AND HEPATOBLASTOMA IN CHILDREN - A CASE-REPORT
    LUTZ, P
    SAUER, P
    MATTER, D
    SAUVAGE, P
    SEILLER, F
    SEGURA, N
    LEVY, JM
    JOURNAL DE MEDECINE DE STRASBOURG, 1983, 14 (08): : 542 - 543
  • [38] Birth characteristics and hepatoblastoma risk in young children
    Reynolds, P
    Urayama, KY
    Von Behren, J
    Feusner, J
    CANCER, 2004, 100 (05) : 1070 - 1076
  • [39] Liver transplantation for hepatoblastoma and hepatocellular cancer in children
    Reyes, J
    Mazariegos, GV
    Carr, B
    Peters, J
    Selby, R
    LIVER TRANSPLANTATION, 2003, 9 (06) : C30 - C30
  • [40] THE PROGNOSTIC IMPLICATION OF HYPERCHOLESTEROLEMIA IN INFANTS AND CHILDREN WITH HEPATOBLASTOMA
    MURAJI, T
    WOOLLEY, MM
    SINATRA, F
    SIEGEL, SM
    ISAACS, H
    JOURNAL OF PEDIATRIC SURGERY, 1985, 20 (03) : 228 - 230